Financhill
Buy
77

KAR Quote, Financials, Valuation and Earnings

Last price:
$18.61
Seasonality move :
3.95%
Day range:
$17.83 - $18.58
52-week range:
$15.44 - $22.47
Dividend yield:
0%
P/E ratio:
40.56x
P/S ratio:
1.13x
P/B ratio:
1.47x
Volume:
845.9K
Avg. volume:
913.6K
1-year change:
7.74%
Market cap:
$2B
Revenue:
$1.8B
EPS (TTM):
$0.46

Earnings Data

Next earnings date for KAR
May 07
2025
Most recent earnings per share
$0.29
Beat by $0.08
(Feb 19/2025)
Consensus Estimate
$0.21
(Feb 19/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KAR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $453M -- -- $0.23 --
05/07/2025 Q1 $444.9M -- -- $0.22 --
02/19/2025 Q4 $416.6M $492M $0.29 $0.21 $0.08
11/06/2024 Q3 $431.7M $448.4M $0.12 $0.22 -$0.10
08/07/2024 Q2 $426.1M $431.8M -$0.00 $0.21 -$0.21
05/01/2024 Q1 $425.1M $416.3M $0.05 $0.21 -$0.16
02/20/2024 Q4 $393M $391.3M $0.02 $0.13 -$0.11
11/01/2023 Q3 -- -- $0.01 $0.15 -$0.14
08/02/2023 Q2 -- -- -$1.87 $0.12 -$1.99
05/02/2023 Q1 -- -- $0.01 $0.09 -$0.08
02/21/2023 Q4 -- -- $0.18 $0.17 $0.01
11/01/2022 Q3 -- -- -$0.15 $0.13 -$0.28
08/02/2022 Q2 -- -- $1.28 $0.07 $1.21
05/03/2022 Q1 -- -- -$0.09 $0.10 -$0.19
02/16/2022 Q4 -- -- $0.04 $0.03 $0.01
11/02/2021 Q3 -- -- -$0.10 $0.10 -$0.20
08/03/2021 Q2 -- -- $0.01 $0.19 -$0.18
05/04/2021 Q1 -- -- $0.25 $0.12 $0.13
02/16/2021 Q4 -- -- -$0.21 $0.28 -$0.49
11/03/2020 Q3 -- -- $0.23 $0.28 -$0.05
08/05/2020 Q2 -- -- -$0.27 -$0.11 -$0.16
05/07/2020 Q1 -- -- $0.02 $0.14 -$0.12
02/18/2020 Q4 -- -- $0.15 $0.29 -$0.14
11/05/2019 Q3 -- -- $0.27 $0.40 -$0.13
08/06/2019 Q2 -- -- $0.30 $0.37 -$0.07
05/07/2019 Q1 -- -- $0.70 $0.77 -$0.07
02/19/2019 Q4 -- -- $0.62 $0.59 $0.03
11/06/2018 Q3 -- -- $0.70 $0.70 -$0.00
08/07/2018 Q2 -- -- $0.82 $0.80 $0.02
05/08/2018 Q1 -- -- $0.82 $0.76 $0.06
02/20/2018 Q4 -- -- $0.63 $0.53 $0.10
10/31/2017 Q3 -- -- $0.57 $0.50 $0.07
08/08/2017 Q2 -- -- $0.65 $0.58 $0.07
05/09/2017 Q1 -- -- $0.62 $0.59 $0.03
02/21/2017 Q4 -- -- $0.45 $0.48 -$0.03
11/03/2016 Q3 -- -- $0.50 $0.53 -$0.03
08/03/2016 Q2 -- -- $0.55 $0.56 -$0.01
05/03/2016 Q1 -- -- $0.55 $0.50 $0.05
02/17/2016 Q4 -- -- $0.40 $0.41 -$0.01
11/05/2015 Q3 -- -- $0.42 $0.44 -$0.02
08/04/2015 Q2 -- -- $0.46 $0.45 $0.01

Openlane Earnings Questions

  • How Much did Openlane Generate in Revenue Last Quarter?

    Openlane reported $492M worth of top line sales in its most recent quarter.

  • Did Openlane Beat Earnings Last Quarter?

    Openlane announced earnings per share of $0.29 which represents a beat of analyst forecast a $0.21 per share.

  • Is Openlane Profitable?

    Openlane reported $124M that represents $1.14 per share over the last quarter.

  • What is the Analyst Consensus for Openlane EPS Next Year?

    Openlane's earnings are forecast to grow from $0.45 per share to $0.85 per share next year representing an increase of 112.97%.

  • When is Openlane's Earnings Date?

    Openlane's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
RGC alert for May 1

Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.

Sell
38
WGS alert for May 1

GeneDx Holdings [WGS] is down 6.85% over the past day.

Sell
43
VICR alert for May 1

Vicor [VICR] is down 1.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock